| Overview |
| bsm-90041r-50µL |
| MAP2K3 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human MEK3 |
| 120-347/347 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5606 |
| P46734 |
| MAP2K3; Mitogen-Activated Protein Kinase Kinase 3; MEK3; MKK3; Stress-Activated Protein Kinase Kinase 2; MAP Kinase Kinase 3; MAPK/ERK Kinase 3; MAPKK3; SAPKK2; PRKMK3; Dual Specificity Mitogen-Activated Protein Kinase Kinase 3; SAPK Kinase 2; EC 2.7.12.2; SAPKK-2; MAPKK 3; MEK 3; Dual Specificity Mitogen Activated Protein Kinase Kinase 3; SKK2 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz